Bristol Myers Squibb Company is a multinational biopharmaceutical company. The Company discovers, develops, licenses, manufactures, markets, distributes and sales biopharmaceutical products. The products of Bristol Myers Squibb Company are sold worldwide to retail pharmacies, wholesalers, government entities, hospitals, and the medical profession. The manufacturing unit of the company is in USA, Puerto Rico and in six other foreign countries. The Bristol Myers Squibb Company launched a subcutaneous formulation of ORENCIA (abatacept) in the USA, NULOJIX (belatacept) in the USA and the European Union which helped the prevention of organ rejection in adult patients who received a kidney transplant.